Cargando…
Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study
OBJECTIVES: To determine the factors associated with the development of methicillin-resistant Staphylococcus aureus (MRSA), hospital stay and mortality, and early versus late MRSA infection. METHODS: Cases (n=44) were intensive care unit (ICU) patients admitted to King Fahd Specialist Hospital, Al-Q...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Saudi Medical Journal
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804236/ https://www.ncbi.nlm.nih.gov/pubmed/33130837 http://dx.doi.org/10.15537/smj.2020.11.25465 |
_version_ | 1783636117926445056 |
---|---|
author | Ali, Mohamed A. Rajab, Ahmad M. Al-Khani, Abdullah M. Ayash, Saleh Q. Basha, Amjad Chamsi Abdelgadir, Ahmed Rajab, Tawfik M. Enabi, Saed Saquib, Nazmus |
author_facet | Ali, Mohamed A. Rajab, Ahmad M. Al-Khani, Abdullah M. Ayash, Saleh Q. Basha, Amjad Chamsi Abdelgadir, Ahmed Rajab, Tawfik M. Enabi, Saed Saquib, Nazmus |
author_sort | Ali, Mohamed A. |
collection | PubMed |
description | OBJECTIVES: To determine the factors associated with the development of methicillin-resistant Staphylococcus aureus (MRSA), hospital stay and mortality, and early versus late MRSA infection. METHODS: Cases (n=44) were intensive care unit (ICU) patients admitted to King Fahd Specialist Hospital, Al-Qassim, Saudi Arabia between 2015 and 2019 who developed MRSA during their hospital stay. Controls (n=48) were patients from the same place and period who did not develop MRSA. Data were abstracted from hospital records. RESULTS: Admission with sepsis (case: 46% vs. control: 2%, p<0.001) and having at least one comorbid condition (case: 95% vs. control: 46%, p<0.001) were significantly associated with the development of MRSA. Age (mean ± SD: case: 65±18, control: 64±18, p=0.7) and gender (% male, case: 52%, control: 56%, p=0.70) were not associated with the development of MRSA. Approximately 73% of all MRSA cases developed within the first 2 weeks of admission. Among the early cases, 44% died during their ICU stay; the corresponding percentage among the late cases was 42% (p=0.69). There was no difference between early and late MRSA cases in terms of non-sepsis admissions (50% vs. 67%, p=0.32) or comorbid status (at least one: 97% vs. 92%, p=0.17). CONCLUSION: Sepsis and comorbid conditions were significant risk factors for MRSA development among hospital patients. |
format | Online Article Text |
id | pubmed-7804236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Saudi Medical Journal |
record_format | MEDLINE/PubMed |
spelling | pubmed-78042362021-03-11 Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study Ali, Mohamed A. Rajab, Ahmad M. Al-Khani, Abdullah M. Ayash, Saleh Q. Basha, Amjad Chamsi Abdelgadir, Ahmed Rajab, Tawfik M. Enabi, Saed Saquib, Nazmus Saudi Med J Original Article OBJECTIVES: To determine the factors associated with the development of methicillin-resistant Staphylococcus aureus (MRSA), hospital stay and mortality, and early versus late MRSA infection. METHODS: Cases (n=44) were intensive care unit (ICU) patients admitted to King Fahd Specialist Hospital, Al-Qassim, Saudi Arabia between 2015 and 2019 who developed MRSA during their hospital stay. Controls (n=48) were patients from the same place and period who did not develop MRSA. Data were abstracted from hospital records. RESULTS: Admission with sepsis (case: 46% vs. control: 2%, p<0.001) and having at least one comorbid condition (case: 95% vs. control: 46%, p<0.001) were significantly associated with the development of MRSA. Age (mean ± SD: case: 65±18, control: 64±18, p=0.7) and gender (% male, case: 52%, control: 56%, p=0.70) were not associated with the development of MRSA. Approximately 73% of all MRSA cases developed within the first 2 weeks of admission. Among the early cases, 44% died during their ICU stay; the corresponding percentage among the late cases was 42% (p=0.69). There was no difference between early and late MRSA cases in terms of non-sepsis admissions (50% vs. 67%, p=0.32) or comorbid status (at least one: 97% vs. 92%, p=0.17). CONCLUSION: Sepsis and comorbid conditions were significant risk factors for MRSA development among hospital patients. Saudi Medical Journal 2020-11 /pmc/articles/PMC7804236/ /pubmed/33130837 http://dx.doi.org/10.15537/smj.2020.11.25465 Text en Copyright: © Saudi Medical Journal http://creativecommons.org/licenses/by-nc This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial License (CC BY-NC), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ali, Mohamed A. Rajab, Ahmad M. Al-Khani, Abdullah M. Ayash, Saleh Q. Basha, Amjad Chamsi Abdelgadir, Ahmed Rajab, Tawfik M. Enabi, Saed Saquib, Nazmus Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study |
title | Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study |
title_full | Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study |
title_fullStr | Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study |
title_full_unstemmed | Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study |
title_short | Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study |
title_sort | methicillin-resistant staphylococcus aureus development in intensive care patients: a case-control study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804236/ https://www.ncbi.nlm.nih.gov/pubmed/33130837 http://dx.doi.org/10.15537/smj.2020.11.25465 |
work_keys_str_mv | AT alimohameda methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy AT rajabahmadm methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy AT alkhaniabdullahm methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy AT ayashsalehq methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy AT bashaamjadchamsi methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy AT abdelgadirahmed methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy AT rajabtawfikm methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy AT enabisaed methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy AT saquibnazmus methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy |